IL6 and COVID-19: Our study seeks to bridge this gap by developing a predictive model that combines cytokine levels (IL-6, TNF-α, IFN-γ), antibody responses (IgG), and comorbid conditions to assess the likelihood of complications, prolonged hospital stays, and mortality in severely ill, unvaccinated COVID-19 patients [13].